Tolvaptan for Primary Aldosteronism and Autosomal Dominant Polycystic Kidney Disease: A Case Report

A 59-year-old Japanese woman was admitted for evaluation of muscle weakness. Autosomal dominant polycystic kidney disease had been diagnosed at the age of 47 years, followed by primary aldosteronism at 53 years. At the age of 58, tolvaptan was started (60 mg/day) to treat her renal disease. After 8...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Case Rep Nephrol Dial
Main Authors: Kunizawa, Kyohei, Hoshino, Junichi, Mizuno, Hiroki, Suwabe, Tatsuya, Sumida, Keiichi, Kawada, Masahiro, Yamanouchi, Masayuki, Sekine, Akinari, Hayami, Noriko, Hiramatsu, Rikako, Hasegawa, Eiko, Sawa, Naoki, Takaichi, Kenmei, Shibata, Shigeru, Ubara, Yoshifumi
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2018
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5903093/
https://ncbi.nlm.nih.gov/pubmed/29692992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000487921
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki